(HealthDay News) — Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the US Food and Drug Administration revisits its Oct. 2 decision to remove the ...

Patients not waitlisted for kidney transplant received breast or prostate cancer screening at lower-than-expected rates, including those with good life expectancy. Breast and prostate cancer ...

(HealthDay News) — For patients with hip fracture, delayed admission is associated with increased mortality risk, according to a study published online in Emergency Medicine Journal.

Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD) warranting optimized management.

(HealthDay News) — There are no significant differences in all-cause or cardiovascular mortality with the prescription of dialysate calcium 1.50 versus 1.25 mmol/L for patients undergoing hemodialysis ...

1 in 5 asymptomatic individuals were antigen-positive versus half of those with ongoing cardiopulmonary, musculoskeletal, and neurologic symptoms ...

Gilead is withdrawing the accelerated approval of Trodelvy (sacituzumab govitecan-hziy) for metastatic urothelial cancer.

The FDA has granted Orphan Drug designation to LQT-1213, a serum glucocorticoid regulated kinase 1 inhibitor, for long QT syndrome.

The presence or absence of left ventricular hypertrophy may predict the effect of finerenone on heart failure hospitalization risk in patients with CKD and type 2 diabetes.

Kidney transplant between donors and recipients with HIV is successful, research shows, which may help addresses the organ ...

Results are from the largest trial assessing acute kidney injury (AKI) after cardiac surgery following extracorporeal blood ...

About one-quarter of fundraising stories had natural language processing outputs for medical financial hardships and health-related social needs ...